A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Clinical trial NCT02365441 · UNKNOWN
Trial details
- NCT number
- NCT02365441
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2023-12-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.